Abbott Diabetes Care IncProduct Pipeline Analysis, 2017 Update
"The Report Abbott
Diabetes Care IncProduct Pipeline Analysis, 2017 Update provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
About
Abbott
Diabetes Care
Market
Abbott Diabetes Care Inc (ADC),
formerly TheraSense Inc, a subsidiary of Abbott Laboratories, is a
medical device company that discovers, develops, manufactures, and
markets pharmaceuticals and medical products for personal use and
hospital use. The companys products include glucose monitoring
systems, diagnostics, medical devices, nutritionals, generic
pharmaceuticals, and diabetes products. Its other products include
barcode readers, removable test strips, port modules, testing strips,
precision insulin systems, and precision glucose test strips. ADC
also provides slim and ultra-lightweight meters, over the counter
test strips, and simple blood glucose and ketone testing meters,
glucose reading meters, among others. The company has its presence in
the US, the Americas, Africa, Asia Pacific, and the Middle East. ADC
and is headquartered in Alameda, California, the US.
Get
Sample copy of this Report @
https://www.marketresearchreports.biz/sample/sample/1492656
This report is a source for data,
analysis, and actionable intelligence on the companys portfolio of
pipeline products. The report provides key information about the
company, its major products and brands.
The report enhances decision
making capabilities and help to create effective counter strategies
to gain competitive advantage.
Scope:
- The report reviews detailed
company profile with information on business description, key company
facts, major products and services, key competitors, key employees,
locations and subsidiaries and recent developments
- The report analyzes all pipeline
products in development for the company Abbott Diabetes Care Inc
-
The report provides pipeline analysis on all pipeline products of the
company (by equipment type, by indication, by development stage, and
by trial status)
- The report covers detailed
information on each pipeline product with information on pipeline
territory, stage of development, device class, regulatory path,
indication(s), application(s) and estimated launch date
- The report provides detailed
description of products in development, technical specification and
functions
- The report also covers ongoing
clinical trials (wherever applicable) with information on trial name,
trial objective, sponsor, trial design , trial status and phase,
estimated start and end date.
Request
for TOC @
https://www.marketresearchreports.biz/reports/1492656/abbott-diabetes-care-incproduct-pipeline-analysis-2017-update-market-research-reports/toc
Reasons to Buy:
- Develop business strategies by
understanding the trends and developments driving the medical devices
pipeline and technology landscape
- Design and develop your product
development, marketing and sales strategies by understanding the
competitor portfolio
- To formulate effective Research
& Development strategies
- Develop market-entry and market
expansion strategies
- Exploit in-licensing and
out-licensing opportunities by identifying products, most likely to
ensure a robust return
- Plan mergers and acquisitions
effectively by identifying key players of the most promising pipeline
- Identify emerging players with
potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Develop competition strategies
by identifying the status and likely launch of the competitors
pipeline products through review of the clinical trials, stage and of
development, etc
- Identify, understand and
capitalize the next high-value products that your competitor would
add in its portfolio
Note: Some sections may be missing
if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Abbott Diabetes Care Inc Company
Overview 5
Abbott Diabetes Care Inc Company
Snapshot 5
Abbott Diabetes Care Inc Pipeline
Products and Ongoing Clinical Trials Overview 5
Abbott Diabetes Care Inc Pipeline
Analysis Overview 8
Abbott Diabetes Care Inc - Key
Facts 8
Abbott Diabetes Care Inc - Major
Products and Services 9
Abbott Diabetes Care Inc Pipeline
Products by Development Stage 10
Abbott Diabetes Care Inc Ongoing
Clinical Trials by Trial Status 12
Abbott Diabetes Care Inc Pipeline
Products Overview 14
FreeStyle Libre Flash Glucose
Monitoring System - Adults 14
FreeStyle Libre Flash Glucose
Monitoring System - Adults Product Overview 14
FreeStyle Libre Flash Glucose
Monitoring System - Adults Clinical Trial 15
FreeStyle Libre Flash Glucose
Monitoring System - Children 18
FreeStyle Libre Flash Glucose
Monitoring System - Children Product Overview 18
FreeStyle Libre Flash Glucose
Monitoring System - Children Clinical Trial 19
FreeStyle Libre Glucose Monitoring
System - Consumer Version 21
FreeStyle Libre Glucose Monitoring
System - Consumer Version Product Overview 21
FreeStyle Libre Glucose Monitoring
System - Consumer Version Clinical Trial 22
Fully Integrated Blood Glucose
Monitoring System 23
Fully Integrated Blood Glucose
Monitoring System Product Overview 23
Abbott Diabetes Care Inc - Key
Competitors 24
Abbott Diabetes Care Inc - Key
Employees 25
Abbott Diabetes Care Inc -
Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Abbott Diabetes Care Inc, Recent
Developments 27
Sep 27, 2017: No More Routine
Finger Sticks for Americans With Diabetes: Abbott's Freestyle Libre
Approved in the U.S. 27
Sep 13, 2017: Freestyle Libre
Flash Glucose Monitoring Technology Gains Reimbursement Approval From
the United Kingdom's National Health Service 28
Aug 31, 2017: Revolutionary
Glucose Monitoring Technology Freestyle Libre Now Reimbursed Across
Japan 29
Aug 08, 2017: FreeStyle Libre
System for People with Diabetes Available for Pre-Order in Canada 29
Jun 29, 2017: Abbott Secures
Health Canada License For Freestyle Libre System For People With
Diabetes 30
May 08, 2017: Abbott Announces
National Reimbursement for FreeStyle Libre in France, Providing
Access to Revolutionary Technology for People with Diabetes 31
Feb 15, 2017: Real-World Data From
Abbott's Freestyle Libre Show Association Between Higher Frequency Of
Glucose Monitoring And Improved Glucose Control For People With
Diabetes 32
Sep 28, 2016: Abbott Receives FDA
Approval for the FreeStyle Libre Pro System, a Revolutionary Diabetes
Sensing Technology for Healthcare Professionals to Use with Their
Patients 33
Jun 13, 2016: Abbott Announces
Positive Results From Groundbreaking Study Of Freestyle Libre System
For People With Type 1 Diabetes 34
Feb 16, 2016: Abbott Receives
Approval In Australia For Freestyle Libre--The Revolutionary Glucose
Monitoring System For People With Diabetes 36
Appendix 37
Methodology 37
About GlobalData 39
Contact Us 39
Disclaimer 40
About us
MarketResearchReports.biz is the
most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Comments
Post a Comment